Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.

MLA

Merchant, Melinda S., et al. “Potential Use of Imatinib in Ewing’s Sarcoma: Evidence for in Vitro and in Vivo Activity.” Journal of the National Cancer Institute, vol. 94, no. 22, Nov. 2002, pp. 1673–79. EBSCOhost, https://doi.org/10.1093/jnci/94.22.1673.

APA

Merchant, M. S., Woo, C.-W., Mackall, C. L., & Thiele, C. J. (2002). Potential use of imatinib in Ewing’s Sarcoma: evidence for in vitro and in vivo activity. Journal of the National Cancer Institute, 94(22), 1673–1679. https://doi.org/10.1093/jnci/94.22.1673

Chicago

Merchant, Melinda S, Chan-Wook Woo, Crystal L Mackall, and Carol J Thiele. 2002. “Potential Use of Imatinib in Ewing’s Sarcoma: Evidence for in Vitro and in Vivo Activity.” Journal of the National Cancer Institute 94 (22): 1673–79. doi:10.1093/jnci/94.22.1673.